We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.77B
AUM Growth
+$1.32B
Cap. Flow
+$729M
Cap. Flow %
8.31%
Top 10 Hldgs %
61.39%
Holding
87
New
3
Increased
26
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$58.8M
2
SCI icon
Service Corp International
SCI
+$52.2M
3
SNPS icon
Synopsys
SNPS
+$47.4M
4
WAT icon
Waters Corp
WAT
+$44.5M
5
PTC icon
PTC
PTC
+$43M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$19.9M
2
QDEL icon
QuidelOrtho
QDEL
+$7.37M
3
KRYS icon
Krystal Biotech
KRYS
+$6.95M
4
LIN icon
Linde
LIN
+$6.15M
5
MSFT icon
Microsoft
MSFT
+$5.07M

Sector Composition

Rank Sector Weight
1 Technology 21.82%
2 Financials 19.71%
3 Healthcare 18.13%
4 Consumer Discretionary 9.67%
5 Consumer Staples 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMYT icon
51
MakeMyTrip
MMYT
$5.32B
$19.7M 0.22%
277,600
+229,600
+478% +$13.1M
GKOS icon
52
Glaukos
GKOS
$9.3B
$18.6M 0.21%
197,212
– –
HUM icon
53
Humana
HUM
$43.8B
$18.2M 0.21%
52,459
– –
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.65B
$18.2M 0.21%
140,329
– –
PEN icon
55
Penumbra
PEN
$12.6B
$17.2M 0.2%
+77,000
New +$19M
SE icon
56
Sea Limited
SE
$66.1B
$17.1M 0.19%
318,417
-1,144
-0.4% -$52.6K
IOVA icon
57
Iovance Biotherapeutics
IOVA
$2.02B
$15.7M 0.18%
1,060,000
-300,000
-22% -$3.49M
INFY icon
58
Infosys
INFY
$50.9B
$14.7M 0.17%
818,723
+77,193
+10% +$1.5M
TFX icon
59
Teleflex
TFX
$5.91B
$13.1M 0.15%
58,000
– –
IONS icon
60
Ionis Pharmaceuticals
IONS
$9.13B
$13M 0.15%
300,000
– –
PRVA icon
61
Privia Health
PRVA
$3.08B
$11.9M 0.14%
610,000
– –
ILMN icon
62
Illumina
ILMN
$29.1B
$10.7M 0.12%
80,161
– –
INSM icon
63
Insmed
INSM
$22.5B
$9.31M 0.11%
343,110
– –
IRTC icon
64
iRhythm Holdings
IRTC
$3.97B
$9.28M 0.11%
80,000
– –
NVCR icon
65
NovoCure
NVCR
$1.77B
$8.15M 0.09%
521,784
– –
CHRS icon
66
Coherus Oncology
CHRS
$217M
$4.61M 0.05%
1,928,464
– –
BEPC icon
67
Brookfield Renewable
BEPC
$5.81B
$2.82M 0.03%
114,736
– –
TMUS icon
68
T-Mobile US
TMUS
$195B
$2.64M 0.03%
16,195
– –
TDOC icon
69
Teladoc Health
TDOC
$1.66B
$2.54M 0.03%
168,000
– –
MCK icon
70
McKesson
MCK
$106B
$2.33M 0.03%
4,332
– –
KPTI icon
71
Karyopharm Therapeutics
KPTI
$154M
$2.27M 0.03%
100,000
– –
OM icon
72
Outset Medical
OM
$86.8M
$2.22M 0.03%
66,667
– –
AZO icon
73
AutoZone
AZO
$51.4B
$2.05M 0.02%
650
+350
+117% +$1M
SAND
74
DELISTED
Sandstorm Gold
SAND
$1.9M 0.02%
361,812
– –
DOX icon
75
Amdocs
DOX
$6.04B
$1.83M 0.02%
20,280
– –
1 2
3
4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2024 Portfolio in Review

As of Q1 2024, C WorldWide Group held 87 positions worth $8.77B, up 18% from $7.45B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

C WorldWide Group deployed $729M of net new capital in Q1 2024, opening 3 new positions and adding to 26 existing holdings. Its largest new stake was Ryan Specialty Holdings: 674,043 shares worth $37.4M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Krystal Biotech, an estimated $6.95M trimmed.

  • C WorldWide Group's largest Q1 2024 buy was Ryan Specialty Holdings: 674,043 shares worth $37.4M.
  • C WorldWide Group added most to NextEra Energy in Q1 2024, an estimated $58.8M increase.
  • C WorldWide Group's biggest Q1 2024 reduction was Krystal Biotech, cutting an estimated $6.95M.
  • C WorldWide Group fully exited Axonics, Inc. Common Stock in Q1 2024, selling an estimated $19.9M.
  • C WorldWide Group's ten largest holdings make up 61% of its $8.77B portfolio in Q1 2024.
  • C WorldWide Group opened 3 new positions and closed 2 in Q1 2024.
  • C WorldWide Group's portfolio value rose 18% quarter-over-quarter to $8.77B.

Based on C WorldWide Group's 13F filing for Q1 2024, filed 3 May 2024.